Biomet Inc.announced today that it has entered into a definitive agreement with Interpore International Inc.under which Biomet will acquire all of the outstanding common stock of Interpore for $14.50 per share, in cash, representing a total equity value of approximately $280 million. Based in Irvine, Calif., Interpore focuses on providing innovative products for spinal surgery.Its three major product groups - spinal implant products, orthobiologic products and minimally invasive surgery products - are used by orthopedic surgeons and neurosurgeons in a wide range of applications.Interpore's net sales in 2003 were approximatley $67.5 million.
Staff Report- | July 28, 2016